![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Mohamed Quresh Wong Tien Y
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.13, Iss.4, 2008-12, pp. : 675-694
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for diabetic retinopathy
By Pipis Antonios Scholl Stefan Augustin Albert J
Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-Angiogenesis Drugs in Diabetic Retinopathy
Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for diabetic neuropathy
By Tahrani Abd A Askwith Trevor Stevens Martin J
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for the treatment of diabetic ulcers
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. :